A prominent side effect of Paclitaxel chemotherapy is sensorimotor peripher
al neuropathy. Leukaemia inhibitory factor (LIF) supports the survival and
regrowth of axotomised sensory and motor neurons and we therefore investiga
ted if systemically administered LIF abrogated Paclitaxel-induced neuropath
y. We found that whereas animals administered Paclitaxel alone exhibited a
significant decrease in the percentage of large myelinated axons, this redu
ction was prevented by the co-administration of LIF. (C) 2001 Elsevier Scie
nce B.V. All rights reserved.